Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Vertex Pharmaceuticals Incorporated (VRTX) is a leading U.S. biopharmaceutical company, headquartered in Boston, ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has not performed well for most of the year, and the company's latest quarterly update ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $417.21, marking a -1.23% move from the previous day. Elsewhere, the Dow saw a downswing of 0.16%, while the tech-heavy Nasdaq ...

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 1.56% on an annualized basis producing an average annual return of 14.01%. Currently, Vertex Pharmaceuticals ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Vertex Pharmaceuticals (VRTX) reports results for the quarter ended September 2025. While this widely-known consensus ...